Phase 1 Study of Mesothelin-ADC
Clinical trial NCT02884726 · COMPLETED
Trial details
- NCT number
- NCT02884726
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-10-14
- Primary completion
- 2017-09-06
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.